Publications by authors named "Jim Janinis"

Claim this Profile
S
Simultaneous pathological findings in biopsy specimens of patients with surgically resected lung carcinoids and their role in survival.
Vasiliki Epameinondas Georgakopoulou, Eleftherios Zygouris, Petros Papalexis, Aikaterini Gkoufa, Christos Damaskos, Jim Janinis

Oncol Lett· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of the immunohistochemistry markers CD56, TTF-1, synaptophysin, CEA, EMA and NSE in surgically resected lung carcinoid tumors.
Vasiliki Epameinondas Georgakopoulou, Eleftherios Zygouris, Christos Damaskos, Aikaterini Pierrakou, Petros Papalexis, Jim Janinis

Mol Clin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Indicators of Survival in Patients With Surgically Resected Lung Carcinoid Tumors at a Greek Medical Center.
Vasiliki E Georgakopoulou, Eleftherios Zygouris, Christos Nikokiris, Christos Damaskos, Aikaterini Pierrakou, Jim Janinis

Cureus· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Jim Janinis, George P Stathopoulos, Pavlos Nikolaidis, Haralambos P Kalofonos, Anna Kalogera-Fountzila

Anticancer Drugs· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second line chemotherapy with 5 fluorouracil and vinorelbine in anthracycline and taxane pretreated patients with metastatic breast cancer.
Evangelia Razis, Paris Kosmidis, Gerassimos Aravantinos, Charalambos Bakoyiannis, Jim Janinis

Cancer Invest· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
Eleni Galani, Joseph Sgouros, Chariklia Petropoulou, Jim Janinis, Gerassimos Aravantinos

Anticancer Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis